TCT 2: Win Ratio Analysis of 1-Year Outcomes in the LANDMARK Trial: Myval vs Contemporary THVs (Sapien or Evolut) in Patients with Symptomatic Severe Aortic Stenosis
We Recommend
Disclosures
<p>Nothing to disclose</p>
Advertisement
Sign In
New at TCTMD? Register today!
Forgot Your Password?
Enter the email you used to register to reset your password.
Search TCTMD
cme